Sharon Yeatts to Clinical Trials as Topic
This is a "connection" page, showing publications Sharon Yeatts has written about Clinical Trials as Topic.
Connection Strength
0.598
-
An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism. Clin Trials. 2022 Dec; 19(6):636-646.
Score: 0.154
-
Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials. J Neurotrauma. 2020 12 15; 37(24):2674-2679.
Score: 0.135
-
Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data. Stroke. 2016 12; 47(12):2931-2937.
Score: 0.104
-
A likelihood-based approach for computing the operating characteristics of the 3+3 phase I clinical trial design with extensions to other A+B designs. Clin Trials. 2015 Feb; 12(1):24-33.
Score: 0.090
-
Designing clinical trials for dystonia. Neurotherapeutics. 2014 Jan; 11(1):117-27.
Score: 0.085
-
Determining the joint effect of obesity and diabetes on functional disability at 3-months and on all-cause mortality at 1-year following an ischemic stroke. BMC Endocr Disord. 2018 Jun 18; 18(1):40.
Score: 0.029